XML 47 R32.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Schedule I - Additional Information of Parent Company
12 Months Ended
Dec. 31, 2023
Condensed Financial Information Disclosure [Abstract]  
Schedule I - Additional Information of Parent Company

SCHEDULE I—ADDITIONAL INFORMATION OF THE PARENT COMPANY

ATRENEW INC.

CONDENSED BALANCE SHEETS

(Amounts in thousands, except for share, per share data or otherwise noted)

 

 

As of December 31,

 

 

2022

 

 

2023

 

 

2023

 

 

RMB

 

 

RMB

 

 

US$

 

ASSETS

 

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

 

34,548

 

 

 

22,199

 

 

 

3,127

 

Prepayments and other receivables, net

 

 

32,403

 

 

 

53,665

 

 

 

7,559

 

Short-term investments

 

 

 

 

 

71,570

 

 

 

10,080

 

Total current assets

 

 

66,951

 

 

 

147,434

 

 

 

20,766

 

Non-current assets:

 

 

 

 

 

 

 

 

 

Long-term investments

 

 

19,806

 

 

 

5,628

 

 

 

793

 

Investments in and amounts due from subsidiaries

 

 

3,783,114

 

 

 

3,559,862

 

 

 

501,396

 

Other non-current assets

 

 

14,909

 

 

 

 

 

 

 

Total Non-current assets

 

 

3,817,829

 

 

 

3,565,490

 

 

 

502,189

 

TOTAL ASSETS

 

 

3,884,780

 

 

 

3,712,924

 

 

 

522,955

 

LIABILITIES

 

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

 

Accrued expenses and other current liabilities

 

 

3,108

 

 

 

1,463

 

 

 

206

 

Total current liabilities

 

 

3,108

 

 

 

1,463

 

 

 

206

 

TOTAL LIABILITIES

 

 

3,108

 

 

 

1,463

 

 

 

206

 

SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

 

 

 

Class A Ordinary shares (US$0.001 par value, 941,472,561 and 941,472,561 shares authorized, 100,854,060 and 102,120,726 shares issued and 96,388,001 and 87,795,879 outstanding as of December 31, 2022 and 2023, respectively)

 

 

609

 

 

 

609

 

 

 

86

 

Class B Ordinary shares (US$0.001 par value, 47,240,103 shares authorized, issued and outstanding as of December 31, 2022 and 2023, respectively)

 

 

305

 

 

 

305

 

 

 

43

 

Class C Ordinary shares (US$0.001 par value, 11,287,336 shares authorized, issued and outstanding as of December 31, 2022 and 2023, respectively)

 

 

7

 

 

 

7

 

 

 

1

 

Additional paid-in capital

 

 

13,131,263

 

 

 

13,268,487

 

 

 

1,868,827

 

Treasury shares (US$0.001 par value, 5,699,315 and 12,240,463 outstanding as of December 31, 2022 and 2023, respectively)

 

 

(217,920

)

 

 

(377,988

)

 

 

(53,238

)

Accumulated deficit

 

 

(9,006,884

)

 

 

(9,163,134

)

 

 

(1,290,600

)

Accumulated other comprehensive loss

 

 

(25,708

)

 

 

(16,825

)

 

 

(2,370

)

TOTAL SHAREHOLDERS’ EQUITY

 

 

3,881,672

 

 

 

3,711,461

 

 

 

522,749

 

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

3,884,780

 

 

 

3,712,924

 

 

 

522,955

 

 

SCHEDULE I—ADDITIONAL INFORMATION OF THE PARENT COMPANY

ATRENEW INC.

CONDENSED STATEMENTS OF COMPREHENSIVE LOSS

(Amounts in thousands, except for share, per share data or otherwise noted)

 

 

Years ended December 31,

 

 

2021

 

 

2022

 

 

2023

 

 

2023

 

 

RMB

 

 

RMB

 

 

RMB

 

 

US$

 

Net revenues

 

 

 

 

 

 

 

 

 

 

 

 

Expenses and (loss) income

 

 

 

 

 

 

 

 

 

 

 

 

Selling and marketing expenses

 

 

(28

)

 

 

 

 

 

(72

)

 

 

(10

)

General and administrative expenses

 

 

(7,228

)

 

 

(15,909

)

 

 

(15,079

)

 

 

(2,124

)

Other operating income

 

 

 

 

 

22,869

 

 

 

9,512

 

 

 

1,340

 

Interest income

 

 

82

 

 

 

 

 

 

 

 

 

 

Interest expenses

 

 

(4,238

)

 

 

(1,297

)

 

 

 

 

 

 

Share of results of equity investees

 

 

 

 

 

 

 

 

(12,644

)

 

 

(1,781

)

Other (loss) income, net

 

 

(43,287

)

 

 

207,914

 

 

 

50,480

 

 

 

7,110

 

Equity in losses of subsidiaries and share of loss from former VIE and former VIE’s subsidiaries

 

 

(761,848

)

 

 

(2,681,514

)

 

 

(188,447

)

 

 

(26,542

)

Net loss attributable to the Company

 

 

(816,547

)

 

 

(2,467,937

)

 

 

(156,250

)

 

 

(22,007

)

Accretion of convertible redeemable preferred shares

 

 

(508,627

)

 

 

 

 

 

 

 

 

 

Net loss attributable to ordinary shareholders

 

 

(1,325,174

)

 

 

(2,467,937

)

 

 

(156,250

)

 

 

(22,007

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to the Company

 

 

(816,547

)

 

 

(2,467,937

)

 

 

(156,250

)

 

 

(22,007

)

Foreign currency translation adjustments

 

 

2,239

 

 

 

(30,030

)

 

 

8,883

 

 

 

1,251

 

Total comprehensive loss

 

 

(814,308

)

 

 

(2,497,967

)

 

 

(147,367

)

 

 

(20,756

)

Accretion of convertible redeemable preferred shares

 

 

(508,627

)

 

 

 

 

 

 

 

 

 

Total comprehensive loss attributable to ordinary shareholders

 

 

(1,322,935

)

 

 

(2,497,967

)

 

 

(147,367

)

 

 

(20,756

)

 

SCHEDULE I—ADDITIONAL INFORMATION OF THE PARENT COMPANY

ATRENEW INC.

CONDENSED STATEMENTS OF CASH FLOWS

(Amounts in thousands, except for share, per share data or otherwise noted)

 

 

Years ended December 31,

 

 

2021

 

 

2022

 

 

2023

 

 

2023

 

 

RMB

 

 

RMB

 

 

RMB

 

 

USD

 

Cash (used in) provided by operating activities

 

 

(4,295

)

 

 

37,835

 

 

 

7,869

 

 

 

1,108

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Purchase of long-term investments

 

 

(32,427

)

 

 

(12,644

)

 

 

 

 

 

 

Purchase of short-term investments

 

 

 

 

 

 

 

 

(71,570

)

 

 

(10,080

)

Investments in and loan to subsidiaries’ and former VIE’s subsidiaries

 

 

(2,589,491

)

 

 

(595,130

)

 

 

(14,573

)

 

 

(2,052

)

Collection of investments in and loan to subsidiaries’ and former VIE’s subsidiaries

 

 

 

 

 

804,743

 

 

 

223,171

 

 

 

31,433

 

Cash (used in) provided by investing activities

 

 

(2,621,918

)

 

 

196,969

 

 

 

137,028

 

 

 

19,301

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from exercise of options

 

 

 

 

 

2,864

 

 

 

2,822

 

 

 

397

 

Repurchase of ordinary shares

 

 

 

 

 

(217,920

)

 

 

(160,068

)

 

 

(22,545

)

Repayment for short-term borrowings

 

 

(32,230

)

 

 

(30,720

)

 

 

 

 

 

 

Proceeds from issuance of convertible redeemable preferred shares

 

 

1,138,232

 

 

 

 

 

 

 

 

 

 

Proceeds from IPO, net of issuance cost of RMB46,931

 

 

1,488,866

 

 

 

 

 

 

 

 

 

 

Cash provided by (used in) financing activities

 

 

2,594,868

 

 

 

(245,776

)

 

 

(157,246

)

 

 

(22,148

)

 

 

 

 

 

 

 

 

 

 

 

 

Net decrease in cash, cash equivalents

 

 

(31,345

)

 

 

(10,972

)

 

 

(12,349

)

 

 

(1,739

)

Cash, cash equivalent at the beginning of the year

 

 

76,865

 

 

 

45,520

 

 

 

34,548

 

 

 

4,866

 

Cash, cash equivalent at the end of the year

 

 

45,520

 

 

 

34,548

 

 

 

22,199

 

 

 

3,127

 

Supplemental cash flow disclosures of continuing operations:

 

 

 

 

 

 

 

 

 

 

 

 

Interest expenses paid

 

 

(4,238

)

 

 

(1,297

)

 

 

 

 

 

 

Supplemental disclosure of non-cash investing and financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of warrant

 

 

10,345

 

 

 

 

 

 

 

 

 

 

 

SCHEDULE I

NOTES TO CONDENSED FINANCIAL INFORMATION OF PARENT COMPANY

1. Schedule I has been provided pursuant to the requirements of Rule 12-04(a) and 5-04(c) of Regulation S-X, which require condensed financial information as to the financial position, changes in financial position and results of operations of a parent company as of the same date and for the same period for which audited consolidated financial statements have been presented when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year.

2. The condensed financial information has been prepared using the same accounting policies as set out in the consolidated financial statements except that the equity method has been used to account for investments in its subsidiaries and former VIE. For the parent company, the Company records its investments in subsidiaries and former VIE under the equity method of accounting as prescribed in ASC 323, Investments—Equity Method and Joint Ventures. Such investments are presented on the Condensed Balance Sheet as “Investments in subsidiaries, former VIE and former VIE's subsidiaries” or and the subsidiaries and former VIE’ profit or loss as “Equity in losses of subsidiaries and share of loss from former VIE and former VIE's subsidiaries” on the Condensed Statements of Comprehensive Income (loss). Ordinarily under the equity method, an investor in an equity method investee would cease to recognize its share of the losses of an investee once the carrying value of the investment has been reduced to nil absent an undertaking by the investor to provide continuing support and fund losses. For the purpose of this Schedule I, the parent company has continued to reflect its share, based on its proportionate interest, of the losses of subsidiaries and former VIE regardless of the carrying value of the investment even though the parent company is not obligated to provide continuing support or fund losses.

3. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The footnote disclosures provide certain supplemental information relating to the operations of the Company and, as such, these statements should be read in conjunction with the notes to the accompanying consolidated financial statements.

4. Besides the guarantee on the short-term borrowings of the subsidiaries as of the year ended December 31, 2023, there were no other material contingencies, significant provisions of long-term obligations, guarantees of the Company for the years ended December 31, 2021, 2022 and 2023.